CLOZARIL Adverse Event: Agranulocytosis
CLOZARIL Adverse Event: Agranulocytosis is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: CLOZARIL; Product category: Drug; Primary reaction: Agranulocytosis.
| Primary drug | CLOZARIL |
|---|---|
| Product category | Drug |
| Primary reaction | Agranulocytosis |
| All reactions | Agranulocytosis; Leukopenia; Neutropenia; White blood cell count increased; Neutrophil count increased |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | CLOZARIL; SODIUM VALPROATE; RISPERIDONE; RISPERIDONE |
| Reporter country | AU |
| Reporter type | 3 |
| Report date | 20140313 |
| Report ID | 10005948 |
$299/mo
Try FDATracker →